Proteomics research in aging: a bibliometric and visualized analysis of evolution and emerging trends (1998-2024 and early 2025)

衰老蛋白质组学研究:演变和新兴趋势的文献计量学和可视化分析(1998-2024 年和 2025 年初)

阅读:1

Abstract

This study aims to analyze the global research landscape and identify emerging trends in research hotspots, key technologies, and clinical applications in proteomics research in aging from 1998 to June 20, 2025. Publications related to aging and proteomics from 1998 to June 20, 2025 were retrieved from the Web of Science Core Collection. A bibliometric analysis was conducted using VOSviewer, CiteSpace, and R 4.3.3 to evaluate publication trends, research collaborations, and emerging topics. A total of 3,638 studies were included in the analysis. The USA, China, and Germany led in publication volume with 983, 829, and 227 articles respectively. Harvard University was the most prolific institution with 306 publications, followed by University of California System and Chinese Academy of Sciences. Key research was published in high-impact journals such as Journal of Proteome Research, Aging Cell, and Proteomics. Luigi Ferrucci, and D. Allan Butterfield were the most influential authors. Cluster analysis identified five research hotspots: protein expression and cellular senescence mechanisms, age-related diseases and neurodegeneration, cellular processes and molecular mechanisms, stress response and longevity mechanisms, and advanced proteomics technologies and biomarker discovery. Burst keyword analysis revealed recent research hotspots including health, dementia, extracellular vesicles and receptor. This study demonstrates that aging proteomics research has matured into distinct yet interconnected domains spanning basic molecular mechanisms, clinical disease applications, and technological innovations, reflecting the field's evolution toward translational and precision medicine approaches for age-related conditions. Future research directions may focus on clinical translation of aging biomarkers and development of precision medicine approaches for age-related diseases.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。